Homologous Recombination Deficiency Solid Tumors
📧 Sign up to get email alerts when something new happens for Homologous Recombination Deficiency Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Niraparib and Dostarlimab in HRD Solid Tumors [Phase 2]
Phase 2 trial update involving niraparib and dostarlimab in homologous recombination deficiency solid tumors (HRD).